Phase 3 Retinal Detachment Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Ursodeoxycholic Acid (UDCA) as a Neuroprotective Adjuvant Treatment to Rhegmatogenous Retinal Detachment Surgery
Retinal Detachment
Hopital Foch120 enrolled2 locationsNCT06294847
Active
Phase 2Phase 3
The effects of memantine versus placebo on visual functions after scleral buckling for regmatogenous retinal detachment (RRD)
patients with rhegmatogenus retinal detachment undergoing scleral buckeling surgery
Tehran University of Medical sciences60 enrolled1 locationACTRN12609000111279